Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,330 | -30,710 | -26,090 | -14,160 | -7,724 |
| Depreciation Amortization | 340 | 1,510 | 1,140 | 760 | 379 |
| Other Working Capital | -1,970 | -3,320 | -1,980 | -1,990 | -474 |
| Other Operating Activity | 1,070 | 690 | 240 | 150 | 79 |
| Operating Cash Flow | $-4,890 | $-31,830 | $-26,690 | $-15,240 | $-7,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -650 | -540 | -360 | -199 |
| Net Acquisitions | 0 | 0 | 0 | 0 | -8,019 |
| Other Investing Activity | 0 | 3,900 | 3,230 | 5,260 | 252 |
| Investing Cash Flow | $-8 | $3,250 | $2,690 | $4,900 | $-7,966 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -10 | 15,680 | 8,570 | 190 | 6 |
| Financing Cash Flow | $-10 | $15,680 | $8,570 | $190 | $6 |
| Beginning Cash Position | 7,400 | 20,290 | 20,290 | 20,290 | 20,296 |
| End Cash Position | 2,480 | 7,400 | 4,870 | 10,150 | 4,596 |
| Net Cash Flow | $-4,910 | $-12,890 | $-15,420 | $-10,140 | $-15,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,890 | -31,830 | -26,690 | -15,240 | -7,740 |
| Free Cash Flow | -4,890 | -31,830 | -26,690 | -15,240 | -7,740 |